期刊文献+

ICU多重鲍曼不动杆菌感染的流行病学调查及耐药性研究 被引量:7

Epidemiological investigation and drug resistance of ICU multiple Acinetobacter infection
下载PDF
导出
摘要 目的探讨ICU多重鲍曼不动杆菌感染的流行病学特征及耐药性。方法回归分析121例鲍曼不动杆菌感染ICU患者临床资料,对分离菌株进行鉴定、药敏试验。结果 121株鲍曼不动杆菌均对米诺环素、多粘菌素B均敏感,部分对头孢哌酮/舒巴坦、亚胺培南敏感。多耐组和非多耐组死亡率差异有统计学意义(P<0.05),且两组年龄、性别、住院时间、混合感染、机械通气、碳青霉烯类抗菌药物、合并慢性阻塞性肺疾病及糖尿病差异均有统计学意义(P<0.05)。年龄、混合感染、机械通气、碳青霉烯类抗菌药物及合并慢性阻塞性肺疾病是多重耐药鲍曼不动杆菌感染的独立危险因素(P<0.05)。结论 ICU多重鲍曼不动杆菌菌株检出率、致死率高,高龄、混合感染、机械通气、碳青霉烯类抗菌药物及合并慢性阻塞性肺疾病是其独立危险因素。 Objective To investigate the epidemiological characteristics of ICU multiple Acinetobacter infection and drug resistance. Methods Regression analysis of 121 cases of Acinetobacter baumannii infection in ICU patients clinical infor- mation, identification, susceptibility testing on isolates. Results All of 121 Aeinetobaeter baumannii are minocycline, and more sticky amphotericin B were sensitive, in part to cefoperazone / sulbactam, imipenem. Multi-resistant group and the non-muhi-resistant group mortality difference was statistically significant (P 〈 0.05), age, gender, duration of hospitaliza- tion, mixed infection, mechanical ventilation, carbapenem antibacterial drugs, chronic obstructive pulmonary disease and diabetes there were significant differences (P 〈 0.05). Age, mixed infection, mechanical ventilation, carbapenem antibiotics and with chronic obstructive pulmonary disease was an independent risk factor for multi-drug resistant Acinetobacter bau- mannii infection (P 〈 0.05). Conclusion ICU multiple Bowman Acinetobacter strain detection rate, death rate, the elderly, mixed infection, mechanical ventilation, carbapenem antimicrobial agents and with chronic obstructive pulmonary disease is an indeoendent risk factor.
作者 林建青
出处 《中国现代医生》 2012年第30期8-10,共3页 China Modern Doctor
关键词 重症监护病房 鲍曼不动杆菌 流行病学调查 多重耐药 药敏试验 危险因素 Intensive care ward Acinetobacter baumannii Epidemiological investigation Multi-drug resistant Suscepti-bility testing Risk factors
  • 相关文献

参考文献10

二级参考文献74

共引文献882

同被引文献89

  • 1周丽萍,严泉,管萍,尤优.浅谈季节变化与气象要素变化对呼吸道疾病的影响[J].当代医药论丛,2014,12(9):3-4. 被引量:6
  • 2Zhou H,Yang Q, Yu YS, et al. Clonal spread of Imipenem-resistant Acinetobacter baumannii among different cities of China[J]. J Clin Micrubiol, 2007,45 : 4054-4057.
  • 3Perez F,Hujer AM,Hujer KM,et al. Global challenge of mul- tidrug-resistant Acinetobacter baumannii [J]. Antimicrob Agents Cheomother, 2007,51 : 3471-3484.
  • 4TURTON JF,KAUFMANN ME,WARNER M,et al.A prevalent,multiresistant clone of Acinetobacter baumannii in southeast England[J].J Hoap Infect,2004,58(3):170-179.
  • 5叶应妩,王敏三,申子瑜.全国临床检验操作规程[M].3版.南京:东南大学出版社,2007:801-880.
  • 6CASTANHEIFA M,TOLEMAN M A,JONES R N,et al.Molecular characterization of a beta-lactamase gene,bla GIM-1,encoding a new subclass of metallo-beta-lactamase[J].Antimicrob Agents Chemother,2004,48:4654-4661.
  • 7LEE K,Y UM JH,YONG D,et al.Novel acquired metallo-betalactamase gene,bla G I M-17,in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea[J].Antimicrob Agents Chemother,2005,49:4485-4491.
  • 8Laxminarayan R,Duse A,Wattal C,et al.Antibiotic resistance-the need for global solutions[J].Lancet Infect Dis,2013,13(12):1057-1098.
  • 9Lemos EV,de la Hoz FP,Einarson TR,et al.Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection:systematic review and meta-analysis[J].Clin Microbiol Infect,2014,20(5):416-423.
  • 10Kang CI,Chung DR,Peck KR,et al.Clinical predictors of Pseudomonas aeruginosa or Acinetobacter baumannii bacteremia in patients admitted to the ED[J].Am J Emerg Med,2012,30(7):1169-1175.

引证文献7

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部